Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-034558
Filing Date
2013-06-12
Accepted
2013-06-12 19:30:33
Documents
1
Period of Report
2013-06-10

Document Format Files

Seq Description Document Type Size
1 OPTION EXERCISE AND SALE rrd383257.html 4  
1 OPTION EXERCISE AND SALE rrd383257.xml 4 11391
  Complete submission text file 0001181431-13-034558.txt   12932
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10450 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
Pratt John (Reporting) CIK: 0001538685 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 13909888